CEOs and companies from Maryland's biotech community were honored today by the Greater Baltimore Committee (GBC) as winners of the sixth annual Maryland Bioscience Awards. The awards were presented during a breakfast ceremony at the University of Maryland BioPark.
University of Maryland President Jay Perman, MD, welcomed the GBC participants to the BioPark and said, "Aside from the tremendous economic benefit to the state from what you do, the most important thing that you do in taking the discoveries from these researchers on this campus and elsewhere is improve the human condition. It means taking brilliant discoveries and bringing them to a needy world."
Winners of the 2011 Maryland Bioscience Awards are:
* Best New Product or Progress: Steven J. Kubisen, PhD, president and CEO
Seguro Surgical, Inc., Columbia. The product is a one-piece, silicone "bowel packing" device for use in abdominal surgery, saving operating room time and reducing the risk of complications from the surgery.
* Leadership in Bioscience Award: Steve Dubin, JD, CPA, CEO, Martek Bioscience Corp., Columbia. Dubin has been with Martek from its beginnings in 1986. The company employs 600 people and generates more than $450 million in annual revenue from its nutritional products.
* Entrepreneurial Spirit Award: Gary Lessing, MBA, president and CEO, Corridor Pharmaceuticals,Inc., Lutherville. Lessing engineered the merger between the company he co-founded, Arginetix, Inc., and Immune Control to form Corridor Pharmaceuticals, which seeks to develop inhibitors to an enzyme for pulmonary hypertension and other conditions.
* President's Award: Carolane Williams, PhD, president, Baltimore City Community College (BCCC), Baltimore. The President's Award this year recognizes the importance of workforce training in the bioscience industry. Through a unique partnership with the UM BioPark, BCCC is addressing the need for a pipeline of high skilled workers for the growing bioscience industry.
"Even in this difficult economic climate, Maryland's bioscience industry has made major steps forward," said GBC President and CEO Donald C. Fry, JD. "These awards are a celebration of our state's vibrant research-driven entrepreneurial sector."
The GBC said in a statement, "Nurturing development of the region's bioscience industry is a top priority of the GBC, the region's most prominent organization of business and civic leaders. Winners of the 2011 Bioscience Awards were selected by a panel of judges from among 19 nominees submitted by businesses, bioscience advocates, higher education institutions and government agencies."
The UM BioPark is home to a growing community of translational research centers, venture-backed life science startups, contract research organizations, and focused educational programs. The 10-acre research park will include 1.8 million square feet of wet lab and office space, parking garages, and landscaped parks at final build-out.
GBC Bioscience Awards 2011 from UMB news on Vimeo.